ÂÜÀòÂÒÂ×

Yoshi Hashimoto has extensive experience in research and development within various biotechnology and pharmaceutical companies. Currently serving as the Director of Novel Vector Development and Platform Development at Carbon Biosciences, Hashimoto previously held roles such as Principal Scientist I at BioMarin Pharmaceutical Inc. and Principal Scientist at Sanofi. With a background in molecular biology, Hashimoto has contributed significantly to the field through projects such as the development of gene knockout baculovirus and the molecular characterization of fire ant viruses. With a PhD in Insect Virology from Nagoya University, Hashimoto's expertise spans across various aspects of gene therapy and virology research.